If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.35    0.00 (0.00%)
Bid:
10.20
Ask:
10.50
Spread: 0.30 (2.941%)
Market Cap: £14.38m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Issue of Shares

17 Nov 2017 12:01

RNS Number : 8522W
Ebiquity PLC
17 November 2017
 

 

Ebiquity Plc

("the Company")

 

Issue of Shares

 

Further to the announcement by the Company on 02 December 2016, Ebiquity plc announces it has issued 600,000 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") as deferred consideration for the acquisition of Stratigent LLC ("Stratigent") in August 2013.

 

The Company had entered into agreements on 17 November 2016 with certain of Stratigent's management team to issue the shares provided they remained employed by the Ebiquity Group for 12 months. All of the management team remain employed by the Ebiquity Group.

 

The issue of shares includes 360,000 Ordinary Shares to Bill Bruno (CEO, North America) representing 0.46% of the Company's issued share capital and 0.49% of the Company's total voting rights.

 

Application has been made for the new Ordinary Shares to be admitted to AIM, with an admission date expected to be 23 November 2017. Upon admission, the shares will rank parri passu in all respects with the existing Ordinary Shares of the Company.

 

Following the anticipated admission of these shares, the total number of ordinary shares in issue will be 78,197,461 with each share carrying the right to one vote. The Ebiquity plc 2000 Employee Benefit Trust holds 4,200,000 issued Ordinary Shares to satisfy certain awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Ordinary Shares held by it. As such 4,200,000 Ordinary Shares are treated as not carrying voting rights. The figure of 73,997,461 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

 

17 November 2017

Dealing Notification Form

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Bill Bruno

 

Reason for the notification

a)

Position/status:

CEO, North America

b)

Initial notification/Amendment:

Initial notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ebiquity plc

b)

LEI:

2138004YRTDJ7FJSWF20

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 25p each

 

b)

Nature of the transaction:

Issue of shares as earn-out consideration

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

N/A

360,000

 

d)

Aggregated information:

· Aggregated volume:

· Price:

· average price of the aggregated transactions.

· N/A

· N/A

e)

Date of the transaction:

17 November 2017

 

f)

Place of the transaction:

 XLON-AIM

 

 

 

Enquiries:

Ebiquity plc

Michael Karg (CEO)

Mark Sanford (Company Secretary)

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

 

020 7650 9600

 

 

 

020 7457 2020

Numis Securities Limited

Nick Westlake Oliver Hardy (NOMAD)

Toby Adcock (Corporate Broker)

020 7260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGMMMMZNGGNZM
Date   Source Headline
29th Jun 202610:00 amRNSCAPITAL MARKETS DAY
28th May 20265:04 pmRNSResult of AGM
1st May 20261:15 pmRNSNotice of ARA and AGM
27th Apr 202611:42 amRNSNotification of Major Holdings
21st Apr 20262:35 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSFinal Results
13th Apr 20261:31 pmRNSNotice of Investor Presentation
13th Apr 20261:29 pmRNSNotice of Results
31st Mar 20267:00 amRNSTotal Voting Rights
20th Mar 20264:17 pmRNSTotal Voting Rights
9th Mar 202612:36 pmRNS-REbiquity Appoints Head of Growth, Americas
6th Feb 202610:03 amRNS-REbiquity Strategic Leadership Appointment
22nd Jan 20267:00 amRNSTrading Update
24th Nov 202512:33 pmRNSTR-1: Notification of Major Holdings
21st Oct 20258:00 amRNS-REbiquity Joins Ad Context Protocol
15th Oct 20259:27 amRNSNotification of Major Holdings
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20251:22 pmRNS-RInvestor Presentation
1st Oct 20251:17 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSTrading Update
16th Sep 20257:00 amRNS-RNotice of Investor Presentation
2nd Sep 20257:00 amRNS-RLaunch of Advisory Board to Drive Strategic Growth
1st Sep 20257:00 amRNSBoard Changes
21st Aug 202511:53 amRNSNotification of Major Holdings
6th Aug 20258:30 amRNSTrading Update and Notice of Interim Results
29th Jul 202511:32 amRNSAllotment of Shares and Total Voting Rights
29th Jul 20259:22 amRNSBoard Appointments
24th Jun 20254:03 pmRNS-REbiquity Strengthens Americas Leadership
10th Jun 20257:00 amRNS-RAwarded Silver as a Top UK Media Consultancy
4th Jun 20255:24 pmRNSResult of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
2nd May 202511:59 amRNSAnnual Report and Notice of Annual General Meeting
22nd Apr 20257:00 amRNSFinal Results
10th Apr 20252:41 pmRNSNotice of Results
9th Apr 20257:00 amRNSNotification of major holdings
31st Mar 20254:33 pmRNSTotal Voting Rights
19th Mar 202510:00 amRNSHolding(s) in Company
19th Mar 202510:00 amRNSHolding(s) in Company
12th Mar 202510:46 amRNSIssue of Shares and TVR
3rd Mar 20257:00 amRNSAppointment of Chief Financial Officer
17th Feb 20257:00 amRNSAppointment of NOMAD and Trading Update
5th Dec 20247:00 amRNSTrading Update
19th Nov 20247:00 amRNSDirectorate Change
3rd Oct 20244:22 pmRNSTotal Voting Rights
30th Sep 20249:27 amRNSNotification of major holdings
26th Sep 20247:00 amRNSInterim Results
23rd Sep 20241:56 pmRNSNotification of major holdings
22nd Aug 202410:55 amRNSTrading Update and Notice of results
22nd Aug 20247:00 amRNSTrading Update and Notice of results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.